The Journal of Organic Chemistry
Article
Methyl 5-(4-Methoxyphenyl)-1,2-diphenyl-4,5-dihydro-1H-pyr-
role-3-carboxylate (5k). According to the general procedure,
cyclopropane 4b (75 mg, 0.242 mmol) was added to a stirring
solution of Ni(ClO4)2·6H2O (13.3 mg, 0.0363 mmol) and aniline
(0.03 mL, 0.290 mmol) in toluene (5 mL) to afford 5k (69.1 mg, 74%
yield) after purification via flash chromatography (25% EtOAc/hexane,
Rf = 0.32) as a yellow oil. 1H NMR (300 MHz, CDCl3): δ 8.24 (d, J =
8.6 Hz, 2H), 7.51−7.45 (m, 7H), 7.28−7.23 (m, 3H), 6.98−6.93 (m,
2H), 4.72 (dd, J = 8.1, 12.3 Hz, 1H), 4.33 (d, J = 15.6 Hz, 1H), 3.65
(d, J = 15.4 Hz, 1H), 3.51 (s, 3H), 3.48−3.41 (m, 1H), 2.81 (dd, J =
8.1, 15.4 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 166.0, 161.8, 150.0,
147.5, 136.3, 131.4, 129.4, 128.7, 128.6, 128.4, 127.7, 127.7, 124.2,
97.2, 63.1, 50.4, 49.3, 38.5. IR: 3028 (s), 2923 (s), 2853 (s), 1664 (s),
1584 (s), 1518 (m) cm−1. HRMS (EI) m/z: [M]+ calcd for
C25H22N2O4, 414.1580; found, 414.1576.
Methyl 1-Benzyl-5-methyl-2,5-diphenyl-4,5-dihydro-1H-pyrrole-
3-carboxylate (5r). According to the general procedure, cyclopropane
4r (75 mg, 0.255 mmol) was added to a stirring solution of Ni(ClO4)2·
6H2O (14.0 mg, 0.0382 mmol) and benzylamine (0.03 mL, 0.306
mmol) in DCM (5 mL) to afford 5r (77.3 mg, 79% yield) after
purification via flash chromatography (25% EtOAc/hexane, Rf = 0.44)
as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.54−7.47 (m, 2H),
7.44−7.28 (m, 8H), 7.19−7.12 (m, 3H), 6.97−6.90 (m, 2H), 4.23 (d, J
= 16.5 Hz, 1H), 3.83 (d, J = 16.7 Hz, 1H), 3.49 (s, 3H), 3.22 (q, J =
15.0 Hz, 2H), 1.64 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 166.5,
161.6, 145.7, 139.5, 132.5, 128.5, 128.4, 128.2, 128.0, 128.0, 127.3,
126.9, 126.6, 125.6, 95.4, 77.4, 77.0, 76.6, 69.4, 50.1, 47.2, 47.0, 25.8.
IR: 3028 (s), 2945 (s), 1732 (s), 1661 (s), 1614 (m), 1580 (m) cm−1.
HRMS (EI) m/z: [M]+ calcd for C26H25NO2, 383.1885; found,.
383.1877.
Methyl 1-Benzyl-2-phenyl-1,3a,4,8b-tetrahydroindeno[1,2-b]-
pyrrole-3-carboxylate (5u). According to the general procedure,
cyclopropane 4u (75 mg, 0.257 mmol) was added to a stirring solution
of Ni(ClO4)2·6H2O (14.1 mg, 0.0385 mmol) and benzylamine (0.03
mL, 0.308 mmol) in toluene (5 mL) to afford 5u (26.9 mg, 37% yield)
after purification via flash chromatography (25% EtOAc/hexane, Rf =
0.20) as a colorless oil. Diastereomeric ratio: 1:1. 1H NMR (300 MHz,
CDCl3): δ 8.05−7.95 (m, 5.25), 7.63−7.55 (m, 2.44), 7.51−7.42 (m,
5.91), 7.41−7.14 (m, 26.79), 4.50 (dd, J = 8.8, 18.1 Hz, 2.00), 4.29 (d,
J = 5.0 Hz, 0.99), 4.10 (d, J = 5.5 Hz, 0.90), 3.97−3.76 (m, 4.81), 3.66
(s, 3.42), 3.61 (s, 3.50), 3.43−3.23 (m, 5.30), 2.80 (dd, J = 5.2, 15.2
Hz, 1.12), 2.56−2.44 (m, 1.35). 13C NMR (75 MHz, CDCl3): δ 169.6,
143.7, 142.0, 141.8, 140.8, 136.8, 133.5, 128.7, 128.3, 127.8, 126.7,
125.0, 124.4, 66.6, 66.4, 57.4, 56.5, 52.4, 50.2, 45.6, 44.9, 35.4, 34.3. IR:
2950 (s), 1734 (s), 1682 (s), 1568 (s), 1512 (s) cm−1. HRMS (EI) m/
z: [M]+ calcd for C26H23NO2, 381.1729; found, 381.1714.
1
Rf = 0.38) as a colorless oil. H NMR (300 MHz, CDCl3): δ 7.46−
7.41 (m, 2H), 7.39−7.33 (m, 2H), 7.33−7.27 (m, 3H), 7.00−6.81 (m,
5H), 6.62−6.57 (m, 2H), 5.07 (dd, J = 6.2, 11.4 Hz, 1H), 3.81 (s, 3H),
3.65 (dd, J = 11.4, 15.3 Hz, 1H), 3.58 (s, 3H), 2.93 (dd, J = 6.2, 15.4
Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 166.3, 158.9, 158.0, 142.8,
136.0, 131.7, 129.7, 128.9, 128.2, 127.5, 123.6, 114.1, 101.1, 68.5, 55.2,
50.4, 39.6. IR: 2947 (s), 1686 (s), 1611 (s), 1588 (s), 1571 (s), 1511
(m) cm−1. HRMS (EI) m/z: [M]+ calcd for C25H23NO3, 385.1678;
found, 385.1680.
Methyl 5-(4-Methoxyphenyl)-2-phenyl-1-((S)-1-phenylethyl)-4,5-
dihydro-1H-pyrrole-3-carboxylate (5n). According to the general
procedure, cyclopropane 4b (75 mg, 0.242 mmol) was added to a
stirring solution of Ni(ClO4)2·6H2O (13.3 mg, 0.0363 mmol) and (S)-
1-phenylethan-1-amine (0.04 mL, 0.298 mmol) in DCM (5 mL) to
afford 5n (90.3 mg, 90% yield) after purification via flash
chromatography (25% EtOAc/hexane, Rf = 0.38) as a colorless oil.
1
Diastereomeric ratio: 1:1. H NMR (300 MHz, CDCl3): δ 7.55−7.42
(m, 9.00), 7.38−7.28 (m, 2.52), 7.28−7.22 (m, 3.20), 7.14−7.09 (m,
1.95), 7.01−6.95 (m, 3.94), 6.93−6.87 (m, 3.49), 6.61−6.55 (m, 1.54),
4.70−4.49 (m, 2.52), 4.40 (dd, J = 6.1, 12.2 Hz, 0.91), 3.83 (s, 3.01),
3.73 (s, 2.48), 3.51−3.41 (m, 6.66), 3.32 (dd, J = 12.2, 15.3 Hz, 1.04),
2.77−2.62 (m, 1.58), 1.39 (d, J = 7.0 Hz, 2.45), 1.08 (d, J = 7.3 Hz,
2.88). 13C NMR (75 MHz, CDCl3): δ 166.6, 166.5, 162.5, 162.1,
158.9, 158.2, 141.3, 140.2, 138.5, 137.2, 133.0, 132.6, 129.2, 129.0,
128.5, 128.3, 128.3, 127.7, 127.6, 127.5, 127.4, 127.0, 126.8, 126.2,
114.1, 113.4, 113.3, 98.7, 96.2, 77.6, 77.1, 76.7, 61.3, 60.7, 55.3, 55.3,
54.8, 54.6, 50.3, 50.2, 39.9, 19.4, 16.2. IR: 2943 (s), 1683 (m), 1611
(s), 1583 (s) cm−1. HRMS (EI) m/z: [M]+ calcd for C27H27NO3,
413.1991; found, 413.1995.
Methyl 1-Benzyl-2,5-diphenyl-4,5-dihydro-1H-pyrrole-3-carboxy-
late (5o). According to the general procedure, cyclopropane 4o (75
mg, 0.242 mmol) was added to a stirring solution of Ni(ClO4)2·6H2O
(14.7 mg, 0.0402 mmol) and benzylamine (0.04 mL, 0.321 mmol) in
toluene (5 mL) to afford 5o (84.2 mg, 85% yield) after purification via
flash chromatography (25% EtOAc/hexane, Rf = 0.48) as a colorless
oil. 1H NMR (300 MHz, CDCl3): δ 7.51−7.25 (m, 13H), 7.01 (dd, J =
1.8, 7.6 Hz, 2H), 4.67 (dd, J = 8.0, 12.3 Hz, 1H), 4.33 (d, J = 15.7 Hz,
1H), 3.70 (d, J = 15.7 Hz, 1H), 3.53 (s, 3H), 3.45 (dd, J = 12.3, 15.3
Hz, 1H), 2.91 (dd, J = 8.0, 15.2 Hz, 1H). 13C NMR (75 MHz,
CDCl3): δ 166.4, 161.9, 142.5, 136.9, 131.9, 128.9, 128.8, 128.4, 128.1,
127.7, 127.6, 127.3, 126.8, 125.8, 96.4, 77.4, 77.0, 76.6, 63.6, 50.1, 48.4,
38.2. IR: 3029 (s), 2946 (s), 1663 (s), 1613 (s), 1579 (s) cm−1. HRMS
(EI) m/z: [M]+ calcd for C25H23NO2, 369.1729; found, 369.1722.
Methyl 1-Benzyl-5-(4-fluorophenyl)-2-phenyl-4,5-dihydro-1H-
pyrrole-3-carboxylate (5p). According to the general procedure,
cyclopropane 4p (70 mg, 0.235 mmol) was added to a stirring solution
of Ni(ClO4)2·6H2O (12.9 mg, 0.0352 mmol) and benzylamine (0.03
mL, 0.282 mmol) in DCM (5 mL) to afford 5p (79.8 mg, 88% yield)
after purification via flash chromatography (25% EtOAc/hexane, Rf =
0.39) as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.49−7.43 (m,
5H), 7.32−7.23 (m, 5H), 7.07 (t, J = 8.7 Hz, 2H), 7.00−6.95 (m, 2H),
4.62 (dd, J = 8.1, 12.3 Hz, 1H), 4.29 (d, J = 15.8 Hz, 1H), 3.65 (d, J =
15.7 Hz, 1H), 3.52 (s, 3H), 3.41 (dd, J = 12.3, 15.3 Hz, 1H), 2.85 (dd,
J = 8.1, 15.3 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 166.4, 163.9,
161.8, 160.6, 138.3, 136.8, 131.8, 129.1, 128.5, 128.2, 127.7, 127.4,
115.8, 115.5, 96.6, 63.0, 50.2, 48.5, 38.4. IR: 2948 (s), 1682 (s), 1610
(s), 1582 (s), 1508 (s) cm−1. HRMS (EI) m/z: [M]+ calcd for
C25H22FNO2, 387.1635; found, 387.1626.
Methyl 1-Benzyl-4-methyl-2,5-diphenyl-4,5-dihydro-1H-pyrrole-
3-carboxylate (5v). According to the general procedure, cyclopropane
4v (71 mg, 0.241 mmol) was added to a stirring solution of
Ni(ClO4)2·6H2O (13.2 mg, 0.0362 mmol) and benzylamine (0.03 mL,
0.290 mmol) in toluene (5 mL) to afford 5v (40.3 mg, 44% yield) after
purification via flash chromatography (25% EtOAc/hexane, Rf = 0.51)
1
as a colorless oil. H NMR (300 MHz, CDCl3): δ 7.52−7.23 (m,
13H), 7.03−6.98 (m, 2H), 4.33 (d, J = 15.7 Hz, 1H), 4.04 (d, J = 5.5
Hz, 1H), 3.70 (d, J = 15.7 Hz, 1H), 3.49 (s, 3H), 3.18−3.08 (m, 1H),
1.28 (d, J = 6.6 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.7, 161.4,
142.1, 137.1, 132.1, 129.0, 128.8, 128.5, 128.2, 127.7, 127.5, 127.3,
126.5, 102.2, 71.7, 50.0, 48.4, 45.6, 21.8. IR: 3029 (s), 2949 (s), 1731
(s), 1665 (s), 1570 (s) cm−1. HRMS (EI) m/z: [M]+ calcd for
C26H25NO2, 383.1885; found, 383.1888.
Methyl 1-Benzyl-2-ethyl-5-(4-methoxyphenyl)-4,5-dihydro-1H-
pyrrole-3-carboxylate (5w). According to the general procedure,
cyclopropane 4w (44 mg, 0.168 mmol) was added to a stirring
solution of Ni(ClO4)2·6H2O (9.20 mg, 0.0252 mmol) and benzyl-
amine (0.02 mL, 0.202 mmol) in DCM (5 mL) to afford 5w (49.1 mg,
85% yield) after purification via flash chromatography (25% EtOAc/
1
hexane, Rf = 0.48) as a yellow oil. H NMR (300 MHz, CDCl3): δ
7.36−7.25 (m, 3H), 7.13−7.04 (m, 4H), 6.86 (dd, J = 2.1, 6.6 Hz,
2H), 4.55−4.45 (m, 2H), 3.88−3.80 (m, 4H), 3.67 (s, 1H), 3.30−3.16
(m, 2H), 2.70 (dd, J = 7.6, 14.9 Hz, 1H), 2.59−2.45 (m, 1H), 1.22 (t, J
= 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 167.2, 165.9, 159.1,
137.2, 134.7, 128.6, 128.1, 127.3, 127.0, 114.0, 92.8, 63.6, 55.2, 50.0,
49.7, 47.0, 37.4, 19.1, 12.7. IR: 2936 (s), 1699 (s), 1669 (s), 1610 (s),
1577 (s), 1511 (m) cm−1. HRMS (EI) m/z: [M]+ calcd for
C22H25NO3, 351.1834; found, 351.1832.
Methyl 1-Benzyl-5-(4-nitrophenyl)-2-phenyl-4,5-dihydro-1H-pyr-
role-3-carboxylate (5q). According to the general procedure,
cyclopropane 4q (45 mg, 0.138 mmol) was added to a stirring
solution of Ni(ClO4)2·6H2O (6.1 mg, 0.0166 mmol) and benzylamine
(0.01 mL, 0.133 mmol) in toluene (5 mL) to afford 5q (14.1 mg, 31%
yield) after purification via flash chromatography (25% EtOAc/hexane,
3037
dx.doi.org/10.1021/jo5001059 | J. Org. Chem. 2014, 79, 3030−3039